Síntesis de compostos organometal·lics d’or(I) amb potencial activitat biològica by Tejero Iborra, M. Àngels
  
 
 
 
 
 
 
 
Treball Fi de Grau 
 
 
 
 
 
 
  
Tutor/s 
Dra. Montserrat Ferrer Garcia 
Departament de Química Inorgànica 
 
Synthesis of gold(I) organometallic compounds with potential 
biological activity 
Síntesis de compostos organometal·lics d’or(I) amb potencial 
activitat biològica 
M. Àngels Tejero Iborra 
June 2012 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aquesta obra esta subjecta a la llicència de: 
Reconeixement–NoComercial-SenseObraDerivada 
 
http://creativecommons.org/licenses/by-nc-nd/3.0/es/ 
   
  
  
 
 
 
 
  
Als meus pares, per el seu suport incondicional, ara i sempre. Als meus professors, a tots ells, 
perquè a més d’ensenyar-me tot el que sé m’han ensenyat el valor de l’esforç. A la Dra. 
Montserrat Ferrer i la Dra. Laura Rodríguez, per la seva direcció i per tot el que he pogut 
aprendre el seu costat durant aquest temps. I a tot el Departament de Química Inorgànica, per 
el seu suport com a col·lectiu.  
Gràcies.  
  
  
  
  
REPORT 
  
 
Synthesis of gold(I) organometallic compounds with potential biological activity 1 
CONTENTS 
SUMMARY 3 
RESUM 5 
INTRODUCTION 7 
OBJECTIVES 13 
RESULTS AND DISCUSSION  14 
FUNCTIONALIZED PHOSPHINE LIGANDS  14 
SYNTHESIS OF GOLD DERIVATIVES 17 
SYNTHESIS OF THE PHOSPHINE LIGAND HMPPE 20 
Phosphorus-Carbon Bond Cleavage to produce mppe 21 
Synthesis of hmppe: Hydroxymethylation of mppe 28 
Phosphine-boranes: protection and separation of phosphine ligands 31 
Formation of mmppe 34 
SYNTHESIS OF THE PHOSPHINE LIGAND Ph2PCH2OH 37 
SYNTHESIS OF THE GOLD(I) COMPLEX [Au(C≡C-C5H4N)(Ph2PCH2OH)]  39 
Synthesis of the gold(I) polymer [Au(C≡C-C5H4N)]n 39 
Synthesis of 4-ethynylpyridine 39 
Polymer Synthesis 40 
Synthesis of [Au(C≡C-C5H4N)(Ph2PCH2OH)]  40 
CONCLUSIONS  45 
EXPERIMENTAL SECTION  47 
GENERAL 47 
CHARACTERIZATION TECHNIQUES 47 
Infrared spectroscopy 47 
Nuclear Magnetic Resonance Spectroscopy 47 
Gas Chromatography-Mass Spectrometry 48 
2 Tejero Iborra, Maria dels Àngels 
Electrospray Ionization-Mass Spectrometry 48 
 
 
 
SYNTHESIS OF [1,2-BIS(PHENYLPHOSPHINO)ETHANE] (MPPE) 48 
SYNTHESIS OF [1,2-BIS(HYDROXYMETHYLPHENYLPHOSPHINO)ETHANE] (HMPPE) 49 
SYNTHESIS OF [1,2-BIS(METHYLMORPHOLINEPHENYLPHOSPHINO)ETHANE] (MMPPE)  49 
SYNTHESIS OF HYDROXYMETHYL(DIPHENYL)PHOSPHINE (Ph2PCH2OH) 50 
SYNTHESIS OF 4-ETHYNYLPYRIDINE (HC≡C-C5H4N) 50 
SYNTHESIS OF [AuCl(tht)]  51 
SYNTHESIS OF [Au(C≡C-C5H4N)]n 51 
ABBREVIATIONS 53 
REFERENCES AND NOTES  55 
 
 
 
 
Synthesis of gold(I) organometallic compounds with potential biological activity 3 
SUMMARY 
One of the main interest of alkynylgold(I) compounds are their therapeutic properties, 
especially their activity as anticancer agents. This TFG focuses on the synthesis of water-
soluble alkynylgold(I) organometallic derivatives that could present biological activity as 
anticancer agents.  
Preliminary experiments with related compounds (derivatives with diphosphine ligands 
containing phenyl substituents), have shown promising results that could be improved by 
increasing the solubility in water of the complexes. The reason is that these present important 
water-solubility problems that preclude their use as drugs.  
The introduction of polar functional groups on the ligands has been studied, to determine 
which functionalized phosphines show more promise as ligands for both water-soluble 
mononuclear and binuclear gold(I) complexes. Subsequently synthesis of monophosphine 
ligand Ph2PCH2OH (1b) and diphosphine [1,2-bis(hydroxymethylphenylphosphino)ethane] 
(hmppe) (1a) was undertaken with successful results.  
 
Figure 1.  
Ligand Ph2PCH2OH was successfully synthesized, but hmppe which was also obtained 
could not be properly isolated. Purification of hmppe was undertaken using borane to form 
phosphine-borane, and the borane group was removed using morpholine. Instead of hmppe we 
obtained the morpholine derivative [1,2-bis(methylmorpholinephenylphosphino)ethane] 
(mmppe) through condensation. This aminomethylphosphine was pure; it does also contain 
side-chains with polar functional groups. Gold(I) compounds bearing this group might be water-
soluble, as such derivatives usually are. 
The synthesis of alkynylgold(I) compounds with phosphine ligand Ph2PCH2OH was 
attempted, by reaction of it with 4-ethynylpyridyinegold(I) polymer. Instead of a stable 
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compound, the gold(I) compound decomposes into several species. It appears that some of 
them might be of polymeric nature, because a very insoluble solid is obtained from the reaction 
mixtures.  
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RESUM 
Un dels principals interessos dels complexos organometàl·lics d’or(I) amb grups alquinil són 
les seves propietats terapèutiques, especialment per la seva activitat com a agents 
anticancerígens. Aquest Treball Final de Grau està enfocat a la síntesi de compostos 
organometallics d’alquinilor(I) solubles en aigua que presentin una potencial activitat biològica 
com a agents anticancerígens.  
Experiments preliminars amb compostos relacionats (derivats amb lligands difosfina que 
contenen substituents fenílics) mostren resultats prometedors que podrien ser millorats 
incrementant la solubilitat en aigua d’aquest tipus de complexes. La raó és que aquests 
presenten problemes importants de solubilitat que dificulten el la seva aplicació com a 
medicaments.  
S’ha estudiat la introducció de grups funcionals polars en lligands fosfina, per tal de 
determinar quines fosfines funcionalitzades són més prometedores tant per a la formació de 
compostos mononuclears com binuclears d’or(I) solubles en aigua. A continuació la síntesi del 
lligand monofosfina Ph2PCH2OH (1b) i del lligand difosfina [1,2-bis(hidroxialquilfenilfosfino)età] 
(hmppe) (1a) s’ha abordat amb resultats positius.  
 
Figura 1.  
El lligand Ph2PCH2OH Ha estat sintetitzat amb èxit, però l’hmppe que també s’ha pogut 
obtenir no ha pogut ser aïllat. La purificació del hmppe s’ha dut a terme utilitzant adductes de 
borà, i el grup borà s’ha eliminat utilitzant morfolina. En lloc d’obtenir hmppe s’ha obtingut el 
derivat de morfolina [1,2-bis(metilmorfolinafenilfosfino)età] (mmppe) per condensació. Aquesta 
aminometilfosfina és pura, conté també cadenes laterals amb grups funcionals de caràcter 
polar. Complexes d’or(I) amb aquest grup podrien ser solubles en aigua, com es el cas de la 
majoria de derivats que contenen aquest grup. 
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La síntesi de compostos d’or(I) amb grups alquinil amb el lligand fosfina Ph2PCH2OH es va 
dur a terme, per reacció amb polímer de 4-etinilpiridinaor(I). En lloc d’un compost compost 
d’or(I) estable, al el compost d’or(I) obtingut descompon en diverses espècies diferents. Tot 
apunta a que algunes d’aquestes espècies pugin tenir naturalesa polimèrica, ja que un solid de 
naturalesa molt insoluble s’obté de la mescla de reacció. 
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INTRODUCTION 
Metal alkynyl complexes have attracted the interest of the scientific community in the last 
decade and a half because of their versatile properties, concretely those of alkynyl complexes 
derived from gold(I) [1]. Research in the synthesis of this family of compounds began with 
Berthelot, who discovered in 1866 the explosive alkynylgold complex Au2C2. Coates and Parkin 
reported the synthesis of alkynylgold(I) phosphine complexes [Au(RC≡C)(PR’3)] in 1962 [2]. They 
were obtained from the reaction of tertiary phosphines with polymeric [AuC≡CR]n. In 1984 Cross 
reported the synthesis of mononuclear alkynylgold(I) complexes [Au(RC≡C)PPh3] by reacting 
terminal acetylene with phosphinegold(I) chlorides [Ph3PAuCl] in the presence of sodium 
ethoxide [3-4].  
Gold(I) shows a clear preference towards linear coordination geometry (Figure 2). Because 
of this and because of the linearity and -unsaturated nature of the acetylide units, 
alkynylgold(I) complexes are attractive building blocks [5]. Alkynylgold(I) complexes are 
especially interesting because of the wide spectrum of potential applications in fields such as 
luminescence, molecular recognition, molecular electronics, optical switches, catalysis and 
materials science [1]. 
 
Figure 2. Basic structure of alkynylgold(I) phosphine complex with linear coordination. 
Alkynylgold(I) complexes as units are able to build supramolecular structures based on their 
tendency to self-assembly through aurophilic interactions. Aurophilicity is that chemical property 
which refers to the tendency of gold complexes towards their aggregation due to the formation 
of weak Au···Au bonds or interactions. The polymetallic aggregates that form this way are 
stabilized by the presence of bridging ligands, of which polyphosphines are one of the most 
common kind. Chemical and physical properties of the compounds are determined by the 
nature of those ligands. Their electronic and especially steric properties have a decisive role in 
the design of supramolecular structures [6]. The possibility to switch ‘on’ and ‘off’ the emission of 
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alkynylgold(I) phosphine complexes by favoring or restricting Au···Au interactions has been 
explored in molecular sensing and optical switching devices.  
Most of the catalytic properties of alkynylgold(I) complexes are because gold is not truly an 
inert metal, and as a transition metal has the ability to behave as a soft Lewis acid. Because of 
this, gold complexes can activate unsaturated functional groups such as alkynes, alkenes and 
allenes to form carbon-carbon and carbon-heteroatom bonds in extremely mild conditions even 
in water media [1]. 
Another application of gold complexes of great historical importance and perhaps even 
greater repercussion is their potential therapeutic use [1][7-8]. Gold complexes have been 
extensively studied because of the clinically established antiarthritic properties of gold(I) 
thiolates such as Myocrisin (aurothiomalate), Solganal (aurothioglucose) o Auranofin ([(1-thio--
D-glucopyranose-2,3,4,6-tetraacetato-S)(triethylphosphine)gold]). Rheumatoid arthritis is the 
most well-known disease treated with gold derivatives. Nonetheless, other afflictions such as 
asthma have been investigated in this regard and there have been successful results in treating 
malaria and cancer (Figure 3).  
Gold complexes with cytotoxic properties are used in cancer treatment and have been found 
to strongly and selectively inhibit enzyme TrxR (Thioredoxine Reductase), which naturally 
defends genetic material from oxidative damage due to oxygen metabolism catalyzing reduction 
of disulphide bond between tioredoxin (TrxR) and other components. It is often found that 
overexpression of TrxR can be found in numerous tumor cell lines. Mechanism is supposedly 
based in the formation of a covalent bond between gold and a selenocysteine residue at the 
active center of the enzyme [9]. It must also be noted that they act as inhibitors of mitochondrial 
function in cancer cells.  
Their pharmacological profile as drugs makes them eligible to substitute more classical 
platinum-based antitumor agents (e.g. cisplatin), because they interact with completely different 
biological targets. The therapeutic effect of cisplatin type drugs is based in metallation and 
adduct formation with DNA. Resistance development effects in cancer treatment can be avoided 
using gold(I) compounds because of their different cellular targets [10].  
Derivatives of phosphinegold(I) have special interest as possible antitumor agents, as most 
biologically active gold drugs include phosphine ligands. There are apparently two types of 
gold(I) phosphine complexes that exhibit important activity against tumor cells [7]: complexes of 
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linear coordination and bis-quelated complexes with tetrahedral coordination geometry (e.g. 
[Au(dppe)2]+). 
 
Figure 3. Gold(I) complexes with antitumor activity: linear coordinated Auranofin (originally an antiarthritic 
drug) (2a), and tetrahedral coordinated [Au(dppe)2]+ (2b). 
Studies indicate that in the series [Au(Ph2P(CH2)nPPh2)2]X, to which lead compound 
[Au(dppe)2]+ belongs, antitumor activity is highest when bridging chain is at an optimal length of 
n = 2-3 carbon units [8][11]. The development of analogous complexes with functionalized 
diphosphines with hydroxymethyl groups has been undertaken with the intention of developing 
possible drugs that result in an increased water-solubility and better water-stability. Compound 
[Au{(HOH2C)2PCH2CH2P(CH2OH)2}2]Cl has been synthesized, along with the linear coordinated 
gold(I) complex [Au2{(HOH2C)2PCH2CH2P(CH2OH)2}2]Cl2, and they both show stability in vivo 
with an elimination via the kidneys. Despite these results, the evaluation of their antitumor 
activity is still pending [12] (Figure 4).  
 
Figure 4. Gold(I) complexes with polar water-soluble phosphine ligands: (2c) 
[Au{(HOH2C)2PCH2CH2P(CH2OH)2}2]Cl and (2d) [Au2{(HOH2C)2PCH2CH2P(CH2OH)2}2]Cl2 
Alkynylgold(I) complexes have been used to a much lesser extent in the research of 
therapeutic drugs. Recently, some complexes containing known antimalarial drug units 
(compounds 3a-c) (Figure 5) have been reported to be active against both cancer cells and 
plasmodium falciparum (the parasite responsible for malaria disease).  
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Figure 5. Some alkynylgold(I) complexes of therapeutic use. 
Alkynylgold(I) complexes bearing water-soluble phosphine ligands such as PTA and DAPTA 
have also been synthesized. Water-soluble phosphines are of special interest in this context to 
try and prevent the marked instability and toxicity found in the traditional triphenylphosphine 
ligand (PPh3) [1].  
A new series of 4-etynylpyridinegold(I) complexes with different phosphine ligands have 
been recently synthesized [13] (Figure 6). These compounds are [Au(C≡CC5H4N)(PPh3)] 
(compound 4a), [Au2(C≡CC5H4N)2(2-diphosphine)] (compounds 4b-4j) in which diphosphine 
ligands are dppm, dppe, dppp, dppb, dppip, dppa, dppf, dcypm and dcypb, and 
[Au3(C≡CC5H4N)3(3-triphos)] (compound 4k).  
 
Figure 6. 4-etynylpyridinegold(I) complexes with mono-, di- and triphosphine ligands. 
The synthesis of compounds with dcypm and dcypb ligands was undertaken to analyze the 
potentially different biological behavior of the compounds taking into account the different 
character of the diphosphines.  
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Preliminary results in enzymatic inhibition studies show that some of the above compounds 
are moderately active against tumor cell growth. In them, TrxR was used as the target enzyme, 
and GR (gluthatione reductase) was used as a control reference to evaluate selectivity of 
enzymatic inhibition (Table 1) [14].  Contrary to TrxR, GR does not contain a selenocysteine in its 
active site, but is otherwise structurally and functionally similar. 
Ligand 
TrxR  
EC50 (M) 
GR  
EC50 (M) 
TrxR/GR MCF-7 HT-29 
dppm    (Ph2PCH2PPh2) >100 >1000 n.a. 0.7±0.1 1.2±0.1 
dppb (Ph2P(CH2)4PPh2) >100 >1000 n.a. 0.8±0.5 2.1±1.1 
dcypm   ((C6H11)2PCH2P(C6H11)2)* >100 >1000 n.a. 9.7±5.3 14.7±2.2 
dcypb ((C6H11)2P(CH2)4P(C6H11)2)* >100 >1000 n.a. >40 >100 
4-ethynylpiridine >100 >1000 n.a. >100 >100 
 
Complex 
TrxR  
EC50 (M) 
GR  
EC50 (M) 
TrxR/GR MCF-7 HT-29 
[Au2(C≡CC5H4N)2(2-dppm)] 1.6±0,3 232±63 145 1.4±0.2 2.7±0.8 
[Au2(C≡CC5H4N)2(2-dppb)] 7.9±4,4 472±23 60 2.8±0.6 1.2±0.2 
[Au2(C≡CC5H4N)2(2-dcypm)]* >50 >500 n.a. 1.1±0.3 0.6±0.2 
[Au2(C≡CC5H4N)2(2-dcypb)]* >50 >500 n.a. 23.8±4.9 15.3±1.6 
Table 1. Results for enzymatic inhibition studies on diphosphine ligands and gold(I) complexes:                 
EC50 values for TrxR and GR, and antiproliferative studies with MCF-7 and HT-29 cells; *: major solubility 
problems were experienced during the biological assays; n.a.: not applicable. 
The half maximal effective concentration (EC50) is a measure of the potency of a drug. It 
refers to the concentration of a drug which induces a response halfway between the baseline 
and maximum after some specified exposure time. Both the gold(I) complexes with dppm and 
dppb turned out to be inhibitors of TrxR with EC50 values below 10μM. Simultaneously they 
show a good selectivity as they only inhibit GR at significantly higher concentrations. This 
makes these compounds good candidates as starting compounds for further development of 
binuclear gold alkynyl anticancer agents. Their activity, however was higher that several other 
mononuclear alkynylgold(I) phosphine complexes [15]. Complexes with dcypm and dcypp do not 
show any significant activity. This suggests that the presence of phenyl groups (C6H5) is directly 
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related to the activity of these series of compounds. Complex with dppm was more active than 
complex with dppb, and this might give a hint that shorter bridging ligands could be preferable 
as far as biological activity is concerned. None of the free diphosphine ligands, as well as 4-
ethynylpyridine were active against TrxR or GR. 
Antiproliferative effects were assessed in two cultured tumor cell lines (NCF-7 breast 
cancer, and HT-29 colon carcinoma cells), and were compared to the metal free ligands. Strong 
antiproliferative effects were observed in the range of 0.7 to 2.8 μM for the active TrxR inhibitors 
(gold complexes with dppm and dppb), and for their respective free phosphine ligands. Thus, 
while well-known, TrxR inhibition cannot be the only mechanism responsible for the cell growth 
inhibition effects of these complexes. In this case, complexes with dcypm and dcypb were also 
moderately active 
The above study pointed that bridged dinuclear gold(I) alkynyl complexes have good 
potential potential for developing biologically active gold(I) complexes. Nonetheless, the main 
disadvantage observed for any potential use of these complexes as antitumor agents is their 
severe solubility problems in the assay conditions. Problematic solubility has already been 
reported recently for other dinuclear species [16]. It may significantly reduce enzymatic activity 
due to insufficient bioavailability. It is reasonable to think that thus, solubility could be an 
important parameter to be researched in regards to these complexes activity in aqueous media.  
Equilibrium between lipophilicity and hydrophilicity in gold complexes with potential 
therapeutic use is a very important parameter in the optimization of their biodistribution, activity 
and selectivity. Specifically, selectivity of gold(I) diphosphine drugs for tumor tissue vs. normal 
tissue could be significantly improved by optimizing the lipophilic-hydrophilic balance of the 
complexes through the design of their ligands [10]. 
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OBJECTIVES 
The objective of this study is to investigate in the synthesis of 4-ethynylpyridinegold(I) 
complexes which may be soluble in water, or at least be more soluble in aqueous media that 
those previously synthesized with ligands such as dppe, dppp, etc. to improve the activity of the 
complexes already studied. These new complexes should be analogous to the series of 
compounds [Au2(C≡CC5H4N)2(2-diphosphine)], or analogous to [Au(C≡CC5H4N)(PPh3)]. 
For this, a thorough research of the state-of-the-art in literature of functionalized phosphines 
and their methods of synthesis has been undertaken. It is intended that a greater solubility in 
gold(I) complexes may be achieved by modification of phosphine ligands, introducing polar 
functional groups in their structure. 
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RESULTS AND DISCUSSION 
FUNCTIONALIZED PHOSPHINE LIGANDS  
The first step in our approach to the synthesis of compounds of the series [Au2(C≡CC5H4N)2 
(2-diphosphine)] which might be both hydrosoluble and biologically active is to select which 
phosphine ligand meets all requisites and shows better synthesis prospects. Preliminary 
information showed that compounds of the series [Au2(C≡CC5H4N)2(Ph2P(CH2)n PPh2)] (A) had 
biological activity. In order to form analogous complexes of greater solubility, the possibility of 
introducing hydroxyalkyl groups in the phosphine ligand as shown in (B) and (C) (Figure 7) was 
envisaged. Hydroxyl functional groups were chosen to render the phosphine ligand more water-
soluble. Sulfonated phosphines are water-soluble too, and are often used to form water-soluble 
complexes. Nonetheless, they are also not completely inert and may affect significantly the 
reactivity of a compound. Because of this our attention was directed only towards phosphines 
containing hydroxyl groups [17]. 
 
Figure 7. The series of complexes A are bioactive, but remarkably insoluble, and this potential drug’s 
solubility problems could be improved by the synthesis of analogous compounds. Series B and C are the 
discussed options for the initial synthesis. 
Synthesis of compounds of C series was discarded promptly because preliminary studies 
suggested that the presence of aromatic phenyl groups in the ligand was fundamental to 
biological activity. While gold(I) complexes with phenyl substituted diphosphine ligands 
[Au2(C≡CC5H4N)2(2-dppm)] and [Au2(C≡CC5H4N)2(2-dppb)] were active, those containing 
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cyclohexyl substituted diphosphine ligands [Au2(C≡CC5H4N)2(2-dcypm)] and [Au2(C≡CC5H4N)2 
(2-dcypb)] were not. Because of this, the series of complexes which synthesis has been 
studied are those of B series, with a diphosphine of with both aromatic and hydroxyalkyl 
substituents. 
Hydroxyalkyl phosphine ligands are an important class of functionalized phosphines that 
combine chemical properties of electron donors and those of hydrophilic alcohols [18]. However, 
while literature on the synthesis and reactivity of diphosphines of the series (HO(CH2)m)2P(CH2)n 
P((CH2)mOH)2 is extensive enough, literature on mixed diphosphine ligands (Figure 8) is scarce 
and synthesis methods described show no contrastable data. Essentially, the synthesis of these 
compounds has been reported by Karasik et. al. [19-20] (2007-2008) and Meier [21] (2004) (Figure 
8). 
 
Figure 8. Mixed diphosphine ligands synthesized by Karasik et. al. (1a and 5a) and Meier (5b). 
Based on the little information available on the topic, we chose to work on the synthesis of a 
diphosphine with a bridging chain of 2 carbon atoms. Extrapolating a parallelism between these 
complexes and other bis-quelated complexes with the same diphosphine ligands, which show 
maximum activity when bridging chain has n = 2 o 3 [9], we opted for the synthesis of a ligand 
with a 2 carbon atoms bridging chain.  
To introduce the hydroxyalkyl groups in the phosphines, several methods exist which can 
introduce hydroxyalkyl groups in primary or secondary phosphines. One must be chosen 
depending on the number m of -CH2- units of the alkyl chain.  
In particular, to introduce an hydroxyalkyl group with m = 1, the insertion of formaldehyde in 
the P-H bond of a primary or secondary phosphine is well documented. Phosphines neat (no 
solvent) react with paraformaldehyde or aqueous formaldehyde 35% (in which case it is 
necessary the use of a catalyst K2[PtCl4]) [18-20][22-29] (Scheme 1) to produce the desired 
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hydroxyalkylated derivative. This is by far the most commonly used method, and can be applied 
to all kinds of phosphines.  
 
Scheme 1. Phosphine hydroxymethylation reaction (insertion of hydroxyalkyl groups m = 1). 
Aqueous hydroxymethylation presents one main disadvantage, in weak acid media in which 
the reaction takes place there can be additional addition of formaldehyde units to form 
phosphonium salts [28] (Scheme 2).  
 
Scheme 2. Formation of phosphonium salts in acid media. 
In order to introduce m = 2 groups in secondary phosphines two methods have been 
reported, one using ethylene oxide [21] and a 2-haloetanol (2-cloroetanol or 2-bromoetanol) [30]. 
The first method uses BuLi as a base to deprotonate the phosphine and form the corresponding 
organolithium species. Then, it reacts with ethylene oxide, and is later hydrolyzed (Scheme 3). 
The second method consists in treating a solution of phosphine and 2-haloetanol with BuLi 
(Scheme 4). 
. 
Scheme 3. Insertion of hydroxyalkyl groups m = 2 by the method described by Meier [21]. 
 
Scheme 4. Insertion of hydroxyalkyl groups m = 2 by the method described by Vargas [30]. 
The main discouraging feature of phosphines with m = 2 is that they possess hydrogen 
atoms in  positions and have a tendency to experience elimination reactions. Because of this 
they are highly unstable and decompose easily.  
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Hydroxyalkyl groups of larger alkyl chains (m > 2) are introduced by the means of allylic 
alcohols or primary olefinic alcohols [31-32]. These are radical reactions that take place in 
aqueous media (Scheme 5).  
 
Scheme 5. Insertion of hydroxyalkyl groups -(CH2)mOH with m > 2. 
Contrasting all the given information we chose to introduce a hydroxyalkyl chain with m = 1. 
Not only these type of phosphine hydroxyalkylation reactions are well-documented, but the 
functionalized phosphines are more stable. Additionally, the shorter alkyl side-chain the more 
polar character of the phosphine, which may result ideally for greater solubility. After all the 
arguments presented above, we decided to undertake the synthesis of [1,2-((hydroxymethyl) 
phenylphosphino)ethane] (hmppe) (Figure 9), to be used in the synthesis of the desired 
ethynylpyridinegold(I) complex. 
 
Figure 9. Ligand hmppe. 
Focus was on synthesis of hmppe ligand, but also of (hydroxymethyl)diphenylphosphine 
(Ph2PCH2OH). Monophosphines are as susceptible as diphosphines to hydroxyalkylation. The 
introduction of hydroxymethyl groups is well-documented. Synthesis of this hydroxymethyl 
functionalized monophosphine was undertaken for comparative purposes.  
SYNTHESIS OF GOLD DERIVATIVES 
We wanted to synthesize two hydroxymethyl phosphine ethynylpyridinegold(I) complexes 
(Figure 10). And a plausible synthesis route was mapped from data extracted from specialized 
literature. In both cases synthesis of hydroxymethyl phosphine ligands and synthesis of 
ethynylpyridinegold(I) polymer are carried out separately, and converge to form gold(I) 
organometallic complexes.  
The proposed synthetic routes for complexes [Au2(C≡C-C5H4N)2(2-hmppe)] and [Au(C≡C-
C5H4N)(Ph2PCH2OH)] are detailed in Schemes 6 and 7.  
 
  
 
 
Scheme 6. Proposed synthesis route for [Au2(C≡C-C5H4N)2(2-hmppe)]. 
  
  
 
 
 
Scheme 7. Proposed synthesis route for [Au(C≡C-C5H4N)(Ph2PCH2OH)]. 
2 
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Figure 10. Complexes [Au(C≡C-C5H4N)(Ph2PCH2OH)] (7a) and [Au2(C≡C-C5H4N)2(2-hmppe)] (7b). 
Synthesis of both ethynylpyridinegold(I) complexes takes place by reaction of 
ethynylpyridinegold(I) polymer with a phosphine ligand. Both reagents are obtained by previous 
separate synthesis. Hydroxymethyl phosphines are obtained by hydroxyalkylation with 
formaldehyde of secondary phosphines. Synthesis of 4-ethynylpyridine precedes the synthesis 
of the gold(I) polymer [Au(C≡C-C5H4N)]n. In both cases the synthesis of gold(I) polymer was 
identical. 
SYNTHESIS OF THE PHOSPHINE LIGAND HMPPE 
The synthesis of hmppe has necessarily to be preceded by the synthesis of [1,2-
bis(phenylphosphino)ethane] (mppe), as hydroxyalkylation reactions with paraformaldehyde 
reactions only take place upon primary and secondary phosphines. Thus, the synthesis of 
hmppe consists of two synthetic steps (Scheme 8). A phosphorus-carbon bond cleavage 
reaction was utilized for the synthesis mppe, the intermediate product. It was followed by a 
hydroxymethylation reaction upon mppe to give hmppe.  
 
 
Scheme 8. Synthetic route for hmppe synthesis.  
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Phosphorus-Carbon Bond Cleavage to produce mppe 
The phosphine ligand mppe is commercial only in the U.S.A. by the company Strem 
Chemicals Inc., but regulations force that in Europe it cannot be obtained with less than a year’s 
notice. Because of this, we synthesized mppe by cleavage of Phosphorus-Carbon bonds from 
the commercial ligand [1,2-bis(diphenylphosphino)ethane] (dppe). The cleavage of P-C can be 
achieved by reaction with lithium in THF, and the resulting lithium phosphide species is 
protonated in a second step by addition of a mixture of water in THF.  
 
Scheme 9. P-C cleavage reaction. 
The preparation of disecondary phosphine (mppe) by the cleavage with lithium of the 
corresponding ditertiary phosphine (dppe) has been widely reported [33-40]. Unfortunately, this 
reaction often yields substantial amounts of alternative byproducts (mostly diphenylphosphine) 
owing to cleavage of a bridging chain P-CH2 bond [33]. During the first step of the reaction, the 
di-lithium species PhP(Li)CH2CH2P(Li)Ph and LiPPh2 are produced through competitive 
cleavage of P-C bonds. It has been proposed that the key in this process lays in different 
leaving group preferences of P-Calkyl and P-Caryl bonds [35] (Scheme 10).  
The cleavage step comprises of a thermodynamic equilibrium involving phosphinyl and 
alkyl/phenyl radicals and anions, followed by the irreversible formation of di-lithium phosphide 
salts [35]. When initial bond cleavage takes place at room temperature (or higher temperature) 
the reaction pathway that originates Ph2PH is favored, and this by-product is obtained in larger 
proportions. At 0 ºC, solutions enriched in 8d are obtained as the reaction pathway that leads to 
the formation of the di-lithium species becomes more favorable. Hydrolysis is another critical 
stage in the reaction, as when carried out at higher temperature significant amounts of Ph2PH 
are generated in this step that do not originate from lithium phosphide species Ph2P(Li) product 
of the first step. Thus, both P-C bond cleavage and protonation step are both dependent on 
temperature.  
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Scheme 10. Competitive reactions that lead to formation of mppe and diphenylphosphine. 
This prompted that earlier methods of synthesis involved a stirring mixture of dppe and 
lithium wire in THF at 0 ºC for a period of 7-18 days [33-34]. We dismissed this method of 
synthesis precisely for the long period of time which it needs in order to be carried out. This is a 
capricious method, and lower yielding but less-time consuming and more reliable routes were 
developed and reported [33][37], mostly optimized by means of trial and error. It is a matter of a 
carefully chosen compromise. The reaction mixture was stirred long enough at 273K to 
overcome the erratic induction of P-Caryl cleavage and to diminish the formation of Ph2PLi. Once 
formed, the di-lithium species is stable to heat, and reflux facilitates the decomposition of side-
product PhLi, thus making the whole process less time-consuming. Protonation to form mppe 
has to be carried again slowly at 0 ºC. As indicated above this step is also crucial to the 
formation of undesired byproducts. 
As both phosphine and lithium phosphide species are highly sensitive to O2 and are easily 
oxidized to corresponding phosphine oxides, all experiments were carried out under N2 
atmosphere by standard Schlenk techniques. The reaction was monitored by 31P{1H} NMR 
Spectroscopy, which is a useful technique to assess purity because it has well-resolved signals. 
Integrations of 31P{1H} NMR Spectra are not useful. Nonetheless, when chemical shift 
difference, Δ, is small and we are working with mixtures of very similar compounds, 
integrations may be tentatively looked at to assess relative concentrations of some species. We 
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used this approximation to judge the production of both secondary phosphines mppe and 
Ph2PH in our experiments.  
We attempted the synthesis of mppe in two occasions. We varied both the concentration 
and the addition rate of dppe upon the lithium suspension on the first step; and both 
temperature and hydrolysis rate of the process in the protonation step following 
recommendations from literature sources [35].  
In the first experiment (experiment 1) we added a solution 0.2 M of dppe in THF over a 
suspension of small pieces of Li, were dppe and Li were in a relative molar proportion of 1 to 10. 
The addition was carried out with a cannula at 0 ºC over 15 min, and the stirring mixture was left 
to react for 1h. To complete the reaction, the solution was refluxed at 80 ºC for 2h. After the 
pieces of Li were filtered, the resulting solution was cooled again to 0 ºC, and quenched with a 
mixture 1:3 H2O/THF. The LiOH precipitate was filtered, and a cloudy yellow solution was 
obtained.  
 
 
Figure 11.  31P{1H} NMR spectrum of reaction mixture after quenching (experiment 1) 
 
 = -13.6 ppm 
 = -41.5 ppm 
 = -47.8,  
-47.9 ppm 
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After quenching, the resulting mixture of phosphines presented four characteristic peaks in 
the 31P NMR spectrum (Figure 11). The desired product mppe appeared as two peaks at (THF, 
insert) = -47.8 and -47.9 ppm, corresponding each to the two possible diastereomers (R*,R*-
(±)/R*,S*) which are formed in equal proportions. Diphenylphosphine (Ph2PH) appeared at 
(THF, insert) = -41.5 ppm, and unreacted dppe appeared at (THF, insert) = -13.6 ppm. 
Selectivity (understood as the number of moles of desired product in relation to number of 
reacted moles) was found to be roughly 33% for mppe.  
As selectivity was so poor, a second experiment was carried out (experiment 2). Two 
essential flaws were detected in experiment 1 that were corrected in experiment 2: the rate of 
dppe addition over the Li suspension was too high, and protonation of the dilithium phosphide 
species was too sudden. This favored too much the diphenylphosphine formation pathway of 
the reaction.  
 
 
 
Figure 12. 31P{1H} NMR spectrum of reaction mixture after quenching (experiment 2) 
 = -13.6 ppm 
 = -41.5 ppm 
 = -47.8,  
-47.9 ppm 
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In experiment 2, a 0.3 M solution of dppe in THF was added dropwise over a suspension of 
small Li pieces (relative molar proportion of 1 to 10) at 0 ºC over 4 h, instead of 15 minutes. The 
solution was refluxed at 80 ºC for 2h. Pieces of Li were filtered while hot, and the solution was 
cooled again to 0 ºC for 30 min. before being quenched with a mixture 1:3 H2O/THF over 
another 30 min. The solution was extracted with Et2O, and extracts were dried with Na2SO4.   
Experiment 2 showed improved selectivity and conversion. 31P {1H} NMR spectra showed 
that the reaction mixture was enriched in mppe (Figure 12), because now selectivity was 
roughly 50%. Conversion in this case proved also higher, leaving a lower fraction of unreacted 
dppe in the reaction mixture.  
Separation of the phosphine mixtures obtained proved to be a critical step in the process of 
obtaining mppe. Once all solvent was eliminated in vacuo, the phosphine mixture was a viscous 
yellow oil at room temperature. This liquid mixture was of difficult separation because of several 
reasons. Phosphines are extremely difficult to separate by chromatography because they are 
unstable to air. On the other hand, dppe, while solid at room temperature, proved to be highly 
soluble in the other liquid phosphines. Because of this, mppe was separated by means of 
vacuum distillation. The phosphines mppe and Ph2PH have very different boiling points, 102 
and 160 ºC respectively (0.1-0.07 mmHg), and dppe has a melting point of 140-145 ºC.  
The oil obtained from experiment 1 was distilled using a Kugelrohr distillation apparatus 
(BUCHI Glass Oven B-580) (Figure 13), a short-path distillation apparatus typically used to 
distill relatively small amounts of compounds with high boiling points under reduced pressure. 
Vapors travel smaller distances in distillation, which helps reduce losses and speeds up 
collection.  
This method proved to be inefficient for the separation of the present phosphine mixture. 
Fraction one collected was enriched in the more volatile Ph2PH, but small amounts of mppe 
were also present (approximate ratio 5:2). Similarly, fraction 2 was significantly enriched in 
mppe, but there still was Ph2PH in the distilled colorless mixture (approximate ratio 5:1). The 
distillation residue presented almost exclusively dppe. One of the main problems with this 
method was that while Kugelrohr distillation provided a short-enough distillation pathway to 
allow distillation to take place over a relatively short time-period, it was too short to render an 
adequate separation (Figure 14). The entire process of experiment 1 was low yielding; 
approximately 11% yield was obtained. 
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Figure 13.  BUCHI Glass Oven B-580, Kugelrohr distillation apparatus. It consists of an electric heater with 
a digital thermostat, and two or more bulbs connected with ground glass joints. The compound to be 
distilled is placed in the last bulb. The other bulbs can be used to collect the distillates sequentially; when 
collecting each desired fraction, that bulb is cooled with ice to aid condensation. A motor drive is used to 
rotate the string of bulbs make distillation more efficient. 
Experiment 2 was carried out in a larger scale and its distillation was achieved by fractional 
distillation in vacuo. Diphenylphosphine distilled at 102 ºC (0.07 mmHg). Once Ph2PH was 
eliminated from the mixture, mppe was separated from dppe by simple distillation so the 
distance vapors had to travel was shorter and the distillation flask had to be heated to a lesser 
degree to achieve distillation in a reasonable amount of time. Phosphine mppe distilled at 160 
ºC (0.07 mmHg) as a clear viscous oil that upon cooling turned into a gummy substance. Not all 
mppe present distilled, as when high temperatures are applied to the distillation flask it formed a 
viscous mass with fused dppe (which does not distill, as it has a much higher boiling point) and 
distillation stopped. 
 
Synthesis of gold(I) organometallic compounds with potential biological activity 27 
 
 
 
Figure 14. 31P{1H} NMR spectra of fractions 1 (top), 2 (middle) and residue (bottom) of Kugelrohr 
distillation of oil resulting from experiment 1.  
This method of distillation proved to be more adequate for the separation of mppe, 
diphenylphosphine and dppe. Nonetheless, it was a more time-consuming method, and the 
phosphine mixture was heated for excessively long periods of time. By heating, the addition of 
oxygen to phosphine becomes more favorable. Even under N2 atmosphere oxide Ph2P(O)H was 
formed during distillation. This too was observed in experiment 1, but to a much lesser extent. 
This phosphine oxide has a melting point of 48-53 ºC and distills at 102 ºC at 0.4 mmHg [41]. 
Diphenylphosphine oxide ((31P{1H} CDCl3) = 21.4 ppm) distilled with Ph2PH, and was initially 
eliminated from solution while diphenylphosphine was distilled. Heating to distill mppe was the 
cause that more diphenylphosphine oxide was formed. It became difficult to eliminate, as further 
heating to distillate only increased the amount of oxide present (Figure 15).  
However, the overall yield of experiment 2 was higher than experiment 1 (approximately 
32%), but mppe obtained contained a significant amount of diphenylphosphine oxide.  
 
dppe mppe Ph2PH 
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Figure 15. 31P{1H} NMR spectra of distilled Ph2PH (top), mppe (middle) and residue (bottom) of fractional 
distillation from experiment 2.  
Synthesis of hmppe: hydroxymethylation of mppe 
Synthesis of hmppe was conducted with the sample of mppe obtained from experiment 2. 
As specified in literature method [19], secondary phosphine mppe neat reacted with solid 
formaldehyde after stirring for four hours at 90 ºC.  
 
 
Scheme 11. Hydroxymethylation reaction of mppe. 
A white semisolid substance was formed which contained white solid particles. This gummy 
substance was dissolved in THF and solid particles were separated from the solution. They 
dppe mppe Ph2PH Ph2(O)PH 
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were characterized with IR Spectroscopy and found to be a mixture of various phosphorus 
oxides (stretching bands (P=O) at 1100-1200 cm-1). 31P{1H}  NMR Spectroscopy of the solution 
showed that the phosphines had become oxidized, and there was present a great variety of 
products, as shown by the big amount of peaks present in the spectrum (Figure16).  
 
Figure 16. 31P{1H} NMR spectrum of the mixture obtained from the hydroxyalkylation of mppe.  
Phosphines appear at negative shifts, as well as most species species with phosphorus(III). 
In this case, it becomes clear that we had not only hmppe, but some other phosphines too, 
which origin we are not quite yet ready to explain. At positive shifts, there are several peaks that 
correspond to phosphine oxides. 
A literature search identified some of the oxides present in more significant proportions as 
can be seen in Figure16 [41-43]. The 31P{1H} NMR shifts of aforementioned phosphorus species 
registered in acetone-d6 trimethylphosphite insert, and CDCl3 if available, are included in Table 
2. There have also been included all other phosphorus species relevant to phosphine ligands 
discussed in this report.  
   
INSERT 
 = 26.1 ppm 
 = 37.8, 
38.5 ppm 
  
Compound 31P {1H} NMR Shifts (CDCl3 300MHz) (ppm) 31P {1H} NMR Shifts (insert 300MHz) (ppm) 
Ph2PCH2CH2PPh2 -12.6 -13.6 
PhPHCH2CH2PHPh -46.8, -47.0 -47.8, -47.9 
Ph(CH2OH)PCH2CH2P(CH2OH)Ph - -18.3, -18.7 
Ph((C4H8NO)CH2)PCH2CH2P(CH2(C4H8NO))Ph -32.7, -33.3 -33.8, -34.4 
Ph2PH -40.3 -41.5 
Ph2PCH2OH - 11.7 -13.7 
Ph(CH2OH)P(O)CH2CH2P(O)(CH2OH)Ph - 37.8, 38.5 
Ph2P(O)H 21.4 21.4 
Ph2P(O)CH2OH 31.1 26.1 
Ph(CH2OH)P(BH3)CH2CH2P(BH3)(CH2OH)Ph -20.0 -20.0 
   
Table 2. NMR Characterization Data for different phosphorus species, both in NMR spectra registered in CDCl3 and other solvents with an acetone-d6 triphosphite 
insert for reference. 
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Given the great quantity of by-products generated by the hydroxyalkylation of mppe, we 
decided to try to separate the surviving phosphine form oxides and other species. Hmppe was 
purified using borane to form phosphine-borane adducts, this step served the purpose of both 
protecting the hydroxymethylated phosphine from oxidation and making it stable enough to 
allow separation. 
Phosphine-boranes: protection and separation of phosphine ligands 
Phosphine-borane complexes are very stable compounds. Their stability allows their use as 
intermediates in synthesis [44], and they can be used as effective protecting groups for active 
phosphorus species such as phosphines. It is common for borane to be used to protect 
phosphines by formation of hydroxyalkyldiphenylphosphine-borane complexes. These not 
sensitive to usual oxidizing agents, including atmospheric oxygen. Decomplexation using 
amines in mild conditions has been described [45].  
In the role of borane-adducts as protecting group for phosphines, it is also common work 
with phosphine-boranes because purification of phosphines becomes easier. In most cases 
separation of phosphine oxides from phosphines is not feasible unless phosphines are 
previously protected. Phosphine-boranes may be separated from oxides by chromatographic 
methods.   
In order to attempt to separate hmppe ligand from the phosphine oxides and other minor 
products in the mixture, the corresponding phosphine-boranes were formed. A solution of 
hydroxyalkylation products in THF was treated with BH3 in THF (1M) (Scheme 12). A semisolid 
substance was obtained, which was washed several times with hexane.  
 
Scheme 12. Phosphine-borane formation reaction. 
31P{1H}  NMR spectrum of the resulting solution showed complete reaction of all phosphines 
(Figure 17). All peaks with negative chemical shifts disappeared. Instead, borane species 
appeared as one single broad signal at 20.0 ppm, as typical of most phosphine-borane adducts.  
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Figure 17. 31P{1H} NMR spectra before (bottom) and after (top) treatment with BH3.  
The phosphine-borane derived from hmppe was separated from various oxides by a 
chromatographic column of silica using CH2Cl2/MeOH as eluent. Different fractions contained 
mixtures of different oxides. Phosphine-borane (Ph(CH2OH)P(BH3)CH2CH2P(BH3)(CH2OH)Ph) 
was obtained pure (Figure 18) as a white semi-crystalline solid, insoluble in non-polar solvents.  
 
Figure 18. 31P{1H} NMR spectrum of Ph(CH2OH)P(BH3)CH2CH2P(BH3)(CH2OH)Ph.  
The next step was deboronation of the phosphine-borane obtained from chromatographic 
purification, in order to obtain the free phosphine ready to be complexed. The method of choice 
was the treatment with a large excess of morpholine as it is rendered in Scheme 13.  
 
INSERT  = 20.0 ppm 
 = 20.0 ppm 
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Scheme 13. Deboronation of hmppe. 
 
 
 
Figure 19. 31P{1H} NMR spectrum of phosphine recovered after deboronation. 
 = -18.3 ppm 
 = -18.7 ppm 
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Deboronation with morpholine at room temperature is a mild procedure. The completion of 
deboronation can be monitored with 31P{1H} NMR Spectroscopy, as with the removal of 
protecting borane group sharp well-defined peaks appear again with negative shifts, instead of 
wide broad band of borane species. Phosphine hmppe was successfully recovered mostly pure 
after 72h of reaction. Chemical phosphorus shifts assigned to (R*,R*-(±)) and (R*,S*) species 
were (morpholine, insert) = -18.29 and -18.69 ppm (Figure 19). The only drawback of this 
method is the high boiling point of morpholine (b.p 120 ºC) which makes difficult the elimination 
of morpholine excess.  
Formation of mmppe  
The morpholine solution containing diphosphine hmppe and the borane-morpholine adduct 
formed during deboronation was dried in vacuum, and a yellow semisolid was obtained. The 
crude mixture was filtered through a neutral alumina column, using toluene as eluent. The 
process was controlled through TLC, and 31P{1H} NMR Spectroscopy. We expected to recover 
pure hmppe, but instead we found that we had obtained a different phosphine with  (31P{1H} 
CDCl3) = -32.7 and -33.3 ppm (Figure 20). 
 
Figura 20. 31P{1H} NMR spectrum of diphosphine recovered after filtration through alumina column. Peaks 
correspond to morpholine derivative.   
 = -32.7 ppm 
 = -33.3 ppm 
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After drying in vacuum the recovered fractions, a white crystalline solid was obtained. It was 
characterized using IR, 1H NMR and 31P{1H} NMR Spectroscopy and MS-ESI. We deduced that 
the resulting compound was [1,2-bis(methylmorpholinephenylphosphino)ethane] (mmppe) 
(Figure 21). 
 
 
 
  
 
Figure 21. 1H NMR spectrum of Ph((C4H8NO)CH2)PCH2CH2P(CH2(C4H8NO))Ph (mmppe), were both 
(R*,R*-(±)/R*,S*) configurations of the diphosphine are included. Splitting of the signal of a protons occurs 
because of a semi-rigid configuration where the proton at one side of the bridge-chain remains nearer the 
Ph substituent than the other. Splitting of b protons occurs because morpholine assumes a chair-like 
conformation, and in this case we can observe the different shifts for axial and equatorial protons in the 
position adjacent to N. Coupling of both a signals, of both b signals and between e and f signals was 
confirmed with a COSY spectrum. 
 
a b c 
c f 
e 
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It appears that by changing the polarity of the medium by introducing a solvent different to 
morpholine, a condensation reaction with morpholine begins in which morpholine acts as a 
nucleophile and substitutes the hydroxyl groups of the side-chains (Scheme 14). This 
morpholine comes from the BH3-morpholine adduct present. The alumina, whose initial purpose 
was to filter the morpholine adduct, apparently acts as a catalyst for this reaction.  
 
Scheme 14. Reaction with hmppe that leads to the formation of mmppe 
A sample of the crude mixture of the diphosphine hmppe and the BH3-morpholine adduct 
diluted in dichloromethane was analyzed with MS-ESI. Results effectively showed the presence 
both of hmppe (m/z (M+) = 307) and protonated morpholine adduct (m/z (M+ + H+) = 102 u. It 
also showed, because of the introduction of another non-polar solvent, the presence of 
morpholine derivative mmppe (m/z (M+) = 445). 
The synthesis of aminomethylphosphines does typically take place starting from 
hydroxymethylphosphines [46]. Although this reaction was not intended, and morpholine was only 
used as the common means for phosphine deboronation, mmppe can not be entirely dismissed.  
Generally speaking methylmorpholinephosphines present several advantages over hydroxy-
methylphosphines. In the first place, while hmppe is reportedly an viscous oil, mmppe is a 
crystalline solid. Also, some morpholine derivatives are water-soluble, and their solutions in 
water and CHCl3 are air-stable. Because of all these reasons, monophosphines bearing 
methylmorpholine substituents have been subject to studies about cytotoxic properties in the 
research for antibacterial drugs [46]. Although this methylmorpholinephosphine is not particularly 
water-soluble, it remains to be seen whether alkynylgold(I) complexes bearing mmppe would 
prove sufficiently soluble. 
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SYNTHESIS OF THE PHOSPHINE LIGAND Ph2PCH2OH 
The synthesis of ligand Ph2PCH2OH was attempted for comparative purposes. Contrary to 
the synthesis of hmppe, this hydroxyalkylated phosphine is relatively common and has been 
well-studied. For this reason, synthesis of Ph2PCH2OH was attempted parallel to that of hmppe, 
utilizing initially the same reaction conditions. 
Diphenylphosphine was treated with the stoichiometric quantity of solid paraformaldehyde to 
produce Ph2PCH2OH [28] in two separate experiments. The reaction time and temperature were 
different in both experiences. Initially diphenylphosphine obtained in the distillation process of 
mppe was used. The product was pure save for the small amounts of oxide developed. 
Diphenylphosphine reacted with paraformaldehyde for four hours at 90 ºC (as for 
hydroxyalkylation of mppe) (Scheme 15). In a second synthesis of Ph2PCH2OH, commercial 
diphenylphosphine reacted with paraformaldehyde for 40 min. at 100-110 ºC. Similar results 
were obtained in both instances.  
 
Scheme 15. Hydroxymethylation of diphenylphosphine.  
In both cases a colorless clear liquid was obtained. The reaction had nearly quantitative 
yield, and control by 31P{1H} NMR showed that ligand Ph2PCH2OH was obtained pure (CDCl3) 
= - 11.7 ppm ((CDCl3) = -11.7 ppm according to literature sources too [47]). There was no oxide 
present in the mixture, neither Ph2P(O)H, nor Ph2P(O)CH2OH.  
It was later observed that in the space of hours to days, Ph2PCH2OH decomposed to form 
another unidentified phosphorus species ((CDCl3) = -19.9 ppm) (Figure 22). The passing of 
time seemed to further degrade the phosphine samples, and increasing amounts of this second 
species could be detected. 
In any case, this phosphorus species does not appear to be a phosphine oxide, and it isn’t a 
phosphinite either, both based on its NMR chemical shift and its apparent later reactivity with 
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[Au(C≡C-C5H4N)]n. Apparently this species does contain active phosphorus, but no P-O bonds. 
Separation of both species was not attempted. 
 
Figure 22. 31P{1H}  NMR Spectra of Ph2PCH2OH ((CDCl3) = - 11.7) sample after decomposition. 
In order to elucidate the nature of the unidentified by-product gas chromatography-mass 
spectrometry (GC-MS) was performed on a sample of the reaction mixture. It did not provide 
any enlightening data in regards to the second phosphine species. On the other hand, the 
presence of the desired phosphine Ph2PCH2OH was confirmed as the main product. We also 
gleaned that Ph2PCH2OH was unstable at high temperature, as main chromatographic peak in 
the spectra was found to belong to Ph2PH. 31P{1H} NMR clearly showed that reagent 
diphenylphosphine was not present when injected, but that Ph2PCH2OH fragmented to present 
a major peak at t = 10.14 s and m/z (M+) = 186 Other minor peaks were t = 11.801 s and m/z 
(M+) = 214, presumably Ph2PCH2O-; at t = 14.787 s and m/z (M+) = 215 appeared vestiges of 
Ph2PCH2OH, and a triphenylphosphine peak at t = 16.249 s and m/z (M+) = 262.  
Looking for a milder form of ionization in mass spectrometry, samples were analyzed with 
Electrospray Ionization-Mass Spectrometry (ESI-MS). Typically, ESI techniques are useful in 
producing ions from large molecules because it overcomes the propensity of said molecules to 
 = -19.9 ppm 
 = -11.7 ppm 
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fragment when ionized. ESI-MS confirmed that the obtained samples contained mainly 
Ph2PCH2OH (m/z (M+H) + = 217). Trimers of phosphorus(V) derived from the phosphine were 
also observed, along with peaks that showed the loss of a formaldehyde (m/z = 689, 659 and 
629). However, it didn’t provide any enlightening information in regards of the phosphine 
byproduct at lower negative phosphorus shifts.  
SYNTHESIS OF THE GOLD(I) COMPLEX [Au(C≡C-C5H4N)(Ph2PCH2OH)]  
For the synthesis of gold(I) complexes exist mainly two synthesis routes, as briefly 
expounded upon in the Introduction. The first one consists on the reaction of the polymer 
[AuC≡CR]n with a tertiary phosphine as described by Coates and Parkin [2] (Scheme 14).  
 
Scheme 16. Scheme for reaction of gold(I) polymer and tertiary phosphines. 
A second choice might be as describe by Cross [3-4] where phosphinegold(I) chlorides 
[Ph3PAuCl] reacted with terminal acetylenes in basic media.  
 
Scheme 17. Scheme for reaction of gold(I) phosphinegold(I) chlorides with alkynyl compounds. 
In this instance, synthesis of [Au(C≡C-C5H4N)(Ph2PCH2OH)] was attempted only by way of 
the polymer-type reaction, as with the previously synthesized [Au(C≡C-C5H4N)(PPh3)] [13].  
Synthesis of the gold(I) polymer [Au(C≡C-C5H4N)]n 
Synthesis of 4-ethynylpyridine 
4-Ethynylpyridine was synthesized [48] by reaction of pyridyl bromide with 2,2-dimethyl-3-
butyn-2-ol in basic media, a protected acetylene commercially available, in the presence of 
catalyst [PdCl2(PPh3)2] and copper(I) iodide. In this manner, acetylide anion reacts with 4-
bromopyridine hydrochloride by nucleophilic aromatic substitution forming a C-C bond. The 
removal of the protecting group as acetone is later accomplished by refluxing with sodium 
hydroxide in toluene.  
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Scheme 18. Schematic 4-ethynylpyridine synthesis. 
 
 
Polymer Synthesis 
The polymer [Au(C≡C-C5H4N)]n was synthesized following a well-established method of 
synthesis [49], where solid [AuCl(tht)] (synthesis described in literature references [50]) reacted 
with 4-ethynylpiridine in basic media. 
 
Scheme 19. Synthesis of alkynylgold(I) polymer of ethynylpyridine 
Leaving group tht is displaced by acetylide anion in the early steps of the reaction. Then 
polymer [Au(C≡C-C5H4N)]n is formed, a pale yellow fine solid that is highly insoluble. As 
expounded by Coates and Parkin [2] a polymer is formed, presumably by  and interactions of 
acetylide triple bond with gold(I). Thus, it has been proposed that such gold(I) polymers have a 
structure such as in Figure 23.  
 
Figure 23. Most likely structure for [Au(C≡C-C5H4N)]n 
Synthesis of [Au(C≡C-C5H4N)(Ph2PCH2OH)] 
Synthesis of [Au(C≡C-C5H4N)(Ph2PCH2OH)] was attempted, with different samples of 
previously synthesized Ph2PCH2OH. In each case, different amounts of unidentified phosphine 
((CDCl3) =   -19.9 ppm) were present in Ph2PCH2OH sample.  
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Every time, Ph2PCH2OH was dissolved in CH2Cl2, and was added over a suspension of 
[Au(C≡C-C5H4N)]n [13] in stoichiometric quantities. Reaction yielded almost immediately a pale 
yellow solution. An immediate 31P{1H} NMR analysis showed the presence of two species in 
solution presenting a phosphorus ligand. Typically 4-ethynylpyridinegold(I) complexes present 
phosphorus shifts around 50-40 ppm [51], whereas in this case phosphorus signals appeared at 
(CH2Cl2, insert) = 33,1 and 29,8 ppm. This allowed us to determine that unfortunately both 
phosphine species had an phosphorus(III) atom, as they both apparently react with the 
ethynylgold(I) polymer (Figure 24).  
 
 
Figure 24. 31P{1H} NMR spectra of reaction mixture. 
From the different intensity of the peaks corresponding to both species formed, we deduced 
that the peak at  = 29.8 ppm could belong to [Au(C≡C-C5H4N)(Ph2PCH2OH)]. Second peak at 
 = 33.05 ppm should belong to a gold(I) complex with the unidentified phosphine ligand. 
Separation of both compounds by chromatography might have been attempted if said 
compounds had proved to be stable enough. But complex [Au(C≡C-C5H4N)(Ph2PCH2OH)] has a 
very short half-life, and hours after reaction a white precipitate appeared. This white precipitate 
INSERT 
 = 29.8 ppm 
42 Tejero Iborra, Maria dels Àngels 
is insoluble in all usual solvents. IR spectrum showed the presence of both phosphine and 
ethynyl ligands.   
In the IR spectrum of ethynylgold(I) complexes the stretching frequency band of the triple 
bond attached to a gold(I) atom is about 2120 cm-1, a shift of approximately 5-20 cm-1 over the 
stretching frequency band of the triple bond in 4-ethynylpyridine ((C≡CH) = 2095 cm-1) [51]. 
This can be observed in the polymer [Au(C≡C-C5H4N)]n where said band appears at ((C≡CH) 
= 2123 cm-1. In this case, stretching frequency band of ethynylpyridine triple bond is 2106 cm-1, 
a somewhat broad band.  It is not clear whether 4-ethynylpyridine is coordinated to gold center 
or remains un-coordinated.  
IR Spectra also presented several other bands demonstrating the presence of phosphine 
ligand: (C=C, Ph) 1587, 1473 and 1430 cm-1, (CH) 739 cm-1, (CC) 687 cm-1 and 
coordination sensitive bands at 509 and 482 cm-1.  
The compound formed is most assuredly a polymer, as all mononuclear gold(I) species 
known to date are soluble. The exact structure of said insoluble polymer could not be 
determined, as NMR characterization was not possible. Possibly, the formation of this polymer 
showed is due to the gold-oxygen interactions, because of hydroxyl group in the phosphine 
ligand.   
This polymer was filtered from solution, and the remaining dichloromethane solution was 
concentrated in vacuo, and subsequently ether was added to precipitate the gold(I) complex [13]. 
A fine pale yellow solid was obtained on precipitation, which was filtered, but characterization 
was not possible because 31P{1H} and 1H NMR analyses showed a dynamic behaviour.  
The 31P{1H} NMR spectrum in chloroform did not present a fine well defined peak, as could 
be seen in the reaction mixture, and as is typical of [Au(C≡C-C5H4N)(PPh3)]. Instead it 
presented a broad band, barely distinguishable from background noise, around  (CDCl3) = 50 
ppm (Figure 25). Possibly this could be caused by a fluxional behavior of phosphine ligands. 
This phosphorus shift is in a range typical of ethynylpyridine(phosphine)gold(I) complexes.  
1H NMR Spectra was not well resolved, but happened to be identical in all experiments. 
Broad signals appeared at  between 9 and 6 ppm, in the aromatic proton region. All peaks 
were ill-defined, wide and flat. This might actually support the existence of a dynamic process. 
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Figure 25. 31P{1H} NMR spectra of isolated yellow precipitate, on both experiments the same behavior was 
observed  (CDCl3) = 50 ppm.  
IR spectra showed that the yellow precipitate contained no ethynylpyridine ligands as 
stretching band (C≡CH) was absent. Bands associated with phosphines could be observed: 
(C=C, Ph) 1430 cm-1, coordination sensitive band at 1095 cm-1, (CH) 1022 cm-1.  
In any case, in solution of CH2Cl2 or CDCl3 this complex [Au(C≡C-C5H4N)(Ph2PCH2OH)] 
rapidly forms more white solid precipitate. This compound is also sensitive to acid media, where 
gold(I) is immediately reduced to metallic gold.  
Furthermore, in ether filtrate solution there were still large quantities of gold(I) complex as in 
dichloromethane reaction mixture. After solvent was removed in vacuo 31P{1H} NMR of the 
remaining cream-colored fine-powdered solid rendered identical shifts for compounds found 
initially in dichloromethane reaction mixture.   
The amount of product that remained in ether solution was significant, and 31P{1H} NMR 
analysis showed the same species were present as after reaction in CH2Cl2. Analysis with ESI-
MS allowed us to confirm that gold compound [Au(C≡C-C5H4N)(Ph2PCH2OH)] is present (m/z 
(M+H) + = 516 u). Other species resulting from the formation of phosphorus(V) adducts were 
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also present.  There is, however, other species which we would be hard-pressed to identify, and 
appear also significantly in the registered spectrum. 
Without entering further speculation, it was not possible to wholly characterize the gold(I) 
compounds obtained from this synthesis. It appears though that complex obtained from this 
synthesis route is both unstable and soluble in non-polar solvents. 
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CONCLUSIONS 
The synthesis of the desired phosphine ligand, [1,2-bis(hydroxymethylphenyl-
phosphino)ethane] (hmppe), has been successfully accomplished.  
Although the cleavage of [1,2-bis(diphenylphosphino)ethane] (dppe) by lithium in THF has 
been reported to be a process largely dependent on both temperature and concentration, large 
amounts of [1,2-bis(phenylphosphino)ethane] (mppe) can be obtained lowering the temperature 
and the concentration at the earlier stages of cleavage reaction. Later, mppe must be separated 
from main side-product diphenylphoshphine by fractional distillation.  
A mixture of phosphines and oxides was obtained as a result of the synthesis of hmppe by 
reaction of mppe with solid paraformaldehyde,. The reaction was not clean, and a purification 
method was devised. Borane-adducts were formed with BH3/THF to protect active phosphorus, 
and thus, they were separated from phosphine oxides by column chromatography. Subsequent 
treatment with morpholine was undertaken in order to remove the borane group and obtain pure 
hmppe. 
Although hmppe can be obtained, contact with other solvents, and filtering through a neutral 
alumina column to remove the morpholine adducts formed during deboronation, lead to the 
formation of a new diphosphine Ph((C4H8NO)CH2)PCH2CH2P(CH2(C4H8NO))Ph (mmppe) 
through a condensation reaction. A white crystalline solid was obtained from this diphosphine 
that was fully characterized. 
The synthesis of phosphine ligand Ph2PCH2OH was also successful, following strictly 
indications given in literature. Nonetheless results were anomalous as a decomposition of the 
phosphine was observed with time.  
As hmppe could not be properly isolated, the synthesis of the corresponding 4-
ethynylpyridinegold(I) complex was not attempted. The synthesis of 4-ethynylpyridinegold(I) 
complexes was attempted only with the phosphine ligand Ph2PCH2OH. It was not possible to 
ascertain whether the resulting complex is more soluble in aqueous media. Instead, we found 
that the complex formed from the reaction of Ph2PCH2OH with 4-ethynylpyridinegold(I) polymer 
is unstable in nature. Apparently, interaction of gold centers with the hydroxyl groups of the 
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functionalized phosphine lead to the formation of insoluble solids that we tentatively assigned to 
polymeric species that could not be fully characterized.  
It appears that gold(I) has a strong affinity for oxygen, and this might lead to unpredictable 
results. A viable alternative would be to use ligands such as mmppe, as they do improve water-
solubility, and have the advantage that are crystalline solids and more stable to oxidation when 
in contact with air (compared to hydroxyalkylphosphines).  
For all that it is yet unknown the effect that these diphosphines might have upon the 
solubility of alkynylgold(I) compounds, they have the advantage of not presenting any free -OH 
groups. Thus it is less likely that they would lead to the formation of polymers in the same 
fashion as observed with Ph2PCH2OH. It would be of interest to be able to synthesize the gold(I) 
complex with mmppe to properly evaluate its water-solubility.  
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EXPERIMENTAL SECTION 
GENERAL 
Synthesis of most compounds described in this report was carried out under nitrogen 
atmosphere, making use of a high vacuum line (Schlenk Line) and standard Schlenk 
techniques.  
Commercial reagents used to carry out the experimental section have been outlined below, 
detailing the company to which they were acquired from. All of them were used without prior 
purification: 4-bromopyridine hydrochloride (Sigma-Aldrich), 2-methyl-3-butyn-2-ol (Fluka), dppe 
(Aldrich), Ph2PH (Aldrich), paraformaldehyde (Panreac), copper(I) iodide (Aldrich), Li (Fluka), 
anhydrous Na2SO4 (Probus), anhydrous MgSO4 (Panreac), NaOAc (Probus), HAuCl4 (Johnson 
Matthey), tht (Merck), NaOH (Panreac), BH3/THF (Aldrich), morpholine (Fluka). Additionally 
dietylamine (Aldrich) was distilled under nitrogen atmosphere over sodium. 
The following solvents were obtained from a Solvent Purification System (Innovative 
Technologies): tetrahydrofuran, diethyl ether, hexane, toluene and dichloromethane. Ethanol, 
methanol and ethyl acetate were used as received without further purification.  
CHARACTERIZATION TECHNIQUES 
Infrared spectroscopy 
Infrared spectra were collected with a FT-IR AVATAR 330 THERMO NICOLET 
spectrophotometer in the interval comprised between 4000 and 400 cm-1, using KBr as 
dispersing medium. 
Nuclear Magnetic Resonance Spectroscopy 
NMR Spectra of 1H and 31P{1H} were registered using spectrometers Varian-Inova 300MHz 
and Varian-Mercury 400MHz. Chemical shifts () are given in ppm an coupling constants (J) in 
Hz. All spectra were recorded at room temperature, and deuterated solvents used are indicated 
in parentheses en each case. In 1H NMR spectroscopy, tetramethylsilane is used as a 
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reference. In 31P{1H} spectroscopy chemical shifts are measured relative to an aqueous solution 
of H3PO4 at 85%. In some cases, in which we worked with reaction mixtures with non-
deuterated solvents, an insert of acetone-d6 with trimethylphosphite was used as an internal 
reference. 
Gas Chromatography-Mass Spectrometry 
The chromatograms and MS spectra described in this report were registered with an 7820A 
GC System chromatograph (Agilent Technologies) equipped with a 5975 Series MSD mass 
spectrometry detector (Agilent Technologies). Chromatography gas was He. The heating 
program used had the sample at 100ºC for two minutes after injection, and after it increased 10 
ºC every minute until it reached 280 ºC, were it remained for 15 min.  
Electrospray Ionization-Mass Spectrometry 
Mass Spectrometry with Electrospray ionization was registered with an LC/MSD TOF 
System form Agilent Technologies with an optically coupled ion detector, an apparatus designed 
for routine high-mass accuracy.  
SYNTHESIS OF [1,2-BIS(PHENYLPHOSPHINO)ETHANE] (MPPE) 
Experimental procedure used for synthesis of mppe is based on literature methods [35], but 
several modifications have been included. A suspension of finely divided lithium (3.5 g : 500 
mmol) in 100 ml THF was cooled to 0ºC. Under vigorous stirring a solution of dppe (20 g : 50 
mmol) in THF (160 ml) was added dropwise to the Li suspension over 4h. After completion of 
the addition, a brown solution was obtained. The reaction mixture was warmed to room 
temperature and heated under reflux for 2h at 80ºC. Solution acquired a darker shade of brown. 
The hot solution was separated from excess lithium with a cannula, and cooled to 0ºC over 30 
min. Mixture was stirred vigorously as 20 ml aqueous THF (20% water) was added dropwise. 
Lithium hydroxide was deposited as a white precipitate. The THF was removed in vacuo, and 
100 ml of water were added to the phosphine mixture. Three extractions of the aqueous phase 
with diethyl ether (3 x 50 ml) followed. The combined organic extracts were dried with 
anhydrous Na2SO4, filtered and concentrated in vacuo. An homogeneous air-sensitive yellow oil 
is obtained, which according to 31P{1H} NMR Spectroscopy contained mppe, diphenylphosphine 
and dppe. Diphenylphosphine distilled (fractional distillation) as a colorless oil having a boiling 
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point of 102ºC (0.1 mmHg). The mppe distilled (simple distillation) at 140ºC (0,07 mmHg), 
yielding 4.00 g of mppe (Yield of 32%).  
31P{1H} NMR (298K, CDCl3): -46.8, -47.0 (R*,R*-(±)/R*,S*). 
1H NMR (298K, CDCl3): 1.80-2.10 (m, 4H, CH2), 3.94 (br s, 1H, PH), 4.65 (br s, 1H, PH), 
7.27 (m, 6H, ArH), 7.48 (m, 4H, ArH). 
SYNTHESIS OF [1,2-BIS(HYDROXYMETHYLPHENYLPHOSPHINO)ETHANE] (HMPPE) 
Solid paraformaldehyde (980 mg : 32.6 mmol) was added to mppe oil (4 g : 16.3 mmol) and 
the reaction mixture was heated at 90ºC for 5h under vigorous stirring. A white rubber with 
suspended white solid was obtained. The rubber was dissolved in THF and the solid was filtered 
from solution with a cannula. The solution was concentrated in vacuo and 32 ml of a BH3/THF 
1M solution were added to form the respective borane-adducts with existing phosphine species. 
The excess BH3 was eliminated in vacuo, and a white gummy solid was obtained. It was 
washed with hexane several times, and was purified with a silica chromatographic column 
(elution mixture was a 5% MeOH in CH2Cl2 solution). Corresponding fractions were dried in 
vacuo, and Ph(CH2OH)P(BH3)CH2CH2P(BH3)(CH2OH)Ph was obtained as a white semi-
crystalline solid (810 mg :2.45 mmol). It was dissolved in 10 ml morpholine, and deboronation 
process was monitored by 31P{1H} NMR Spectroscopy to completion (72 h). 
31P{1H} NMR (298K, CDCl3): -18.3, -18.7 (R*,R*-(±)/R*,S*). 
SYNTHESIS OF [1,2-BIS(METHYLMORPHOLINEPHENYLPHOSPHINO)ETHANE] (MMPPE) 
Mixture of hmppe and morpholine-BH3 in excess morpholine was dried in vacuo. A yellow 
semisolid was obtained containing all non-volatile components. The crude mixture was passed 
through a neutral alumina column and eluted with toluene. Process was monitored with TLC and 
31P{1H} NMR, and all fractions containing the diphosphine were dried in vacuo. The entire 
process yielded a white crystalline solid. 
IR (KBr cm-1): 1550 (C=C st.), 1285 ( C-H), 1007 ( C-H), 869 ( C-H), 741 ( C-H). 
31P{1H} NMR (298K, C6D6): -32.7, -33.3 (R*,R*-(±)/R*,S*). 
1H NMR (298K, C6D6): 1.89 (m, 2H, P-CHH bridging chain), 2.00 (m, 2H, P-CHH bridging 
chain), 2.29 (m, 4H, N-CHH morpholine), 2.45 (m, 4H, N-CHH morpholine), 2.61 (m, 4H, P-CH2-
N), 3.54 (m, 8H, O-CH2 cycle), 7.39 (m, 6H, ArH), 7,50 (m, 4H, ArH orto).  
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SYNTHESIS OF HYDROXYMETHYL(DIPHENYL)PHOSPHINE (Ph2PCH2OH) 
Solid paraformaldehyde (200 mg : 6.66 mmol) was added to diphenylphosphine oil (1 ml : 
6.66 mmol) and the reaction mixture was heated at 100-110ºC under vigorous stirring for 30 
min. A clear oil was obtained in near quantitative yield.  
31P{1H} NMR (298K, CDCl3):  -11.7 
1H NMR (298K, CDCl3): 2.55 (br s, 1H, OH), 4.30 (d, 2H, JP-H = 7,96 Hz, CH2), 7.2-7.4 (m, 
10H, ArH). 
SYNTHESIS OF 4-ETHYNYLPYRIDINE (HC≡C-C5H4N) 
Experimental procedure used for synthesis of 4-ethynylpyridine is based on literature 
methods [47], but several modifications have been included. Initially, 2.52 g (12.86 mmol) of 4-
bromopyridine hydrochloride were dissolved in 10 ml of recently distilled NHEt2. Addition of 1.4 
ml (14,33 ml) of 2-methyl-3-butyn-2-ol was followed cooling to 0 ºC in an ice bath. Then 85 mg 
(0.12 mmol) of [PdCl2(PPh3)2] and 14 mg (0,06 mmol) of CuI were added. After 15 min ice bath 
was retired. Resulting suspension was stirred all night, while protected from light with tinfoil. 
Then the suspension had acquired a greenish color and pasty quality, at which point it was dried 
in vacuo. The solid obtained was dissolved in CH2Cl2 (25 ml) obtaining an amber solution. Said 
solution was the washed with H2O (2 x 10ml). Organic phase was dried with anhydrous MgSO4, 
filtered and dried in vacuo. The solid obtained was filtered through a chromatographic column of 
silica gel (40 g), and eluted with hexane : ethyl acetate 1 : 4. They were obtained 683 mg of 2-
methyl-4-(4-pyridyl)-3-butyn-2-ol (a yellow solid) with 33% yield. 
Product obtained was dissolved in 25 ml toluene, and 0.17 g (4,23 mmol) of ground NaOH 
were added to solution. It was heated at reflux (111ºC) for two hours. The resulting brown 
solution was filtered from precipitate, and was dried in vacuo, obtaining a brown solid. Product 
was sublimated in vacuo (heating 40 ºC), and 164 mg of 4-ethynylpyridine (white crystalline 
solid) were obtained. Yield was 13%.  
IR (KBr cm-1): 3136 (st. C-H), 2095 (st. C≡CH), 1592, 1436 and 1404 (C=C, skeletal 
vibrations).  
1H NMR (298K, CDCl3): 4.01 (s, 1H, C≡CH), 7.35 (d, J(H-H) = 5,8 Hz, 2H, H-py), 8.59 (d, 
J(H-H) = 5,8 Hz, 2H, Hα-py). 
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SYNTHESIS OF [AuCl(tht)] 
The synthesis of [AuCl(tht)] was carried out as in literature [50]. First, 4.65 g (13,69 mmol) of 
HAuCl4 were dissolved in 8 ml of deoxygenated H2O and 40 ml EtOH. Solution was orange at 
this point, and was stirred for 15 min. Then 2.1 ml (23.79 mmol) of tht were added dropwise to 
the solution, and it was stirred for 30 min. A white precipitate appeared, which was filtered and 
washed with EtOH. Process yielded 3.07 g of [AuCl(tht)] (70%).  
SYNTHESIS OF [Au(C≡C-C5H4N)]n 
In a mixture of THF/MeOH (42 ml, 1:1) 4-ethynylpyridine (150 mg : 1.40 mmol), [AuCl(tht)] 
(451 mg : 1.40 mmol) and sodium acetate (575 mg : 7.01 mmol) were dissolved. Flask was 
covered with tin foil to protect reaction mixture from light. After 40 min. the pale-yellow solid in 
suspension is filtered with a canula, and washed with THF/ MeOH 1:1. Solvent is removed in 
vacuo. Process yielded 280 mg of [Au(C≡C-C5H4N)]n  (69%).  
IR (KBr cm-1): 2123 (st. C≡CH). 
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ABBREVIATIONS 
 
DAPTA 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane 
dcypb [1,4-bis(dicyclohexylphosphino)butane] 
dcypm [bis(dicyclohexylphosphino)methane] 
dppa [bis(diphenylphosphino)acetylene] 
dppb [1,4-bis(diphenylphosphino)butane] 
dppe [1,2-bis(diphenylphosphino)ethane] 
dppf [1,1’-bis(diphenylphosphino)ferrocene] 
dppip [bis(diphenylphosphino)isopropane] 
dppm [bis(diphenylphosphino)methane] 
dppp [1,3-bis(diphenylphosphino)propane] 
GC-MS Gas Chromatography-Mass Spectrometry 
hmppe [1,2-bis(hydroxymethylphenylphosphino)ethane] 
IR Infrarred 
mmppe [1,2-bis(methylmorpholinephenylphosphino)ethane] 
mppe [1,2-bis(phenylphosphino)ethane] 
MS-ESI Electrospray Ionization Mass Spectrometry 
NMR Nuclear Magnetic Resonance 
PTA l,3,5-triaza-7-phosphaadamantane 
py pyridine 
tht tetrahydrotiophene 
triphos [1,1,1-tris(diphenylphosphinometil)ethane] 
TrxP Tioredoxine reductase 
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